Genomic Health
North America, California, United States, Redwood City
Description
Genomic Health is a provider of genomic-based diagnostic tests that address overtreatment and optimal treatment of early-stage cancer.
Investor Profile
Genomic Health has made 5 investments, with 0 in the past 12 months and 20% as lead.
Stage Focus
- Series E (40%)
- Series D (20%)
- Series F (20%)
- Convertible Note (20%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Hospital
- Precision Medicine
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
